gammadeltaTCR ligands and lineage commitment.
Two major T lymphocyte lineages--alphabeta and gammadelta T cells--develop in the thymus from common precursors. Differentiation of both lineages requires signals coming from TCRs. Development of alphabeta T cells is driven at early stages by signaling from the pre-TCR, most likely in a ligand-independent fashion, and later--by signals delivered by alphabetaTCRs binding to their ligands--classical or non-classical MHC molecules. gammadelta lineage cells likewise require TCR signaling for their differentiation. Recent work from several groups suggests that TCR signaling not only ensures the developmental progression towards alphabeta and gammadelta lineages but that signal strength instructs lineage fate: weaker TCR signal results in alphabeta and stronger--in gammadelta lineage commitment. However, as most gammadeltaTCRs remain orphan receptors, it is still debated whether strong signals from gammadeltaTCRs in development are generated in a ligand-dependent manner (as in the case of alphabetaTCRs), ligand-independent manner (as for pre-TCR) or both. Here we summarize evidence supporting a possible role for ligands in gammadelta T cell lineage commitment and the generation of gammadelta sublineages.
Kreslavsky
Taras
T
Laboratory of Lymphocyte Biology, Cancer Immunology & AIDS, Dana-Farber Cancer Institute, 44 Binney Street, Smith 736, Boston, MA 02115, USA.
von Boehmer
Harald
H
D000818:Animals; D019070:Cell Lineage; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D008024:Ligands; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000276:immunology* / Q000378:metabolism; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism
D006649:Histocompatibility Antigens; D008024:Ligands; D016692:Receptors, Antigen, T-Cell, gamma-delta
Curr Opin Immunol. 2006 Oct;18(5):539-46
16870417
J Immunol. 2003 Sep 1;171(5):2413-20
12928388
Immunity. 2004 Jul;21(1):121-31
15345225
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14741-6
16203967
Cell. 1989 May 19;57(4):667-74
2524273
Immunity. 2002 May;16(5):707-18
12049722
Scand J Immunol. 2003 Sep;58(3):374-81
12950685
Immunity. 2009 Oct 16;31(4):565-75
19833086
Nature. 1989 Aug 24;340(6235):646-50
2528072
J Exp Med. 2006 Jun 12;203(6):1543-50
16754716
Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):653-7
1346234
Adv Immunol. 2004;84:201-38
15246254
Nature. 1988 Aug 4;334(6181):395-402
3043226
Science. 2004 Oct 8;306(5694):269-71
15472075
Semin Immunol. 2010 Aug;22(4):207-13
20430644
Nat Immunol. 2008 Jul;9(7):777-84
18516039
Nature. 1986 Aug 28-Sep 3;322(6082):836-40
2943999
Nature. 1989 May 18;339(6221):230-1
2654648
J Exp Med. 1991 Jan 1;173(1):231-40
1702138
Immunity. 2005 Jan;22(1):71-80
15664160
Immunity. 2008 Mar;28(3):346-58
18342007
Nature. 1992 Nov 19;360(6401):225-31
1359428
Science. 2005 Apr 8;308(5719):227-31
15821084
Science. 2005 Apr 8;308(5719):252-5
15821090
Science. 1998 Mar 13;279(5357):1737-40
9497295
Nature. 2000 Aug 3;406(6795):524-7
10952314
Eur J Immunol. 1992 Feb;22(2):491-8
1311262
Immunity. 2006 Jul;25(1):105-16
16814577
J Immunol. 2009 Feb 15;182(4):1892-900
19201842
J Immunol. 2010 Feb 1;184(3):1268-79
20038637
Immunity. 2008 Sep 19;29(3):391-403
18703361
Science. 2004 Jul 9;305(5681):248-51
15247480
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Mar 25;786(1-2):297-304
12651026
Nat Immunol. 2008 Sep;9(9):1055-64
18660811
Immunity. 1996 Oct;5(4):343-52
8885867
J Immunol. 2009 May 1;182(9):5306-16
19380777
Eur J Immunol. 1997 Feb;27(2):544-53
9045929
Cell. 1990 Aug 10;62(3):549-61
2379238
Cell. 1990 Oct 19;63(2):333-40
2208290
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5928-32
2788280
J Exp Med. 1997 Oct 20;186(8):1269-75
9334366
J Immunol. 1994 Feb 15;152(4):1578-88
8120371
Teratology. 1999 Oct;60(4):226-39
10508976
Mol Cell Biol. 2006 Jun;26(12):4642-51
16738328
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12453-8
19617548
PLoS One. 2010 Feb 19;5(2):e9303
20174563
PLoS One. 2008 Jan 30;3(1):e1512
18231598
J Immunol. 2004 Dec 1;173(11):6515-20
15557139
Nat Immunol. 2006 Sep;7(9):995-1003
16878135
J Autoimmun. 2010 Jun;34(4):478-84
20080388
J Immunol. 2009 May 1;182(9):5165-9
19380758
Eur J Immunol. 1993 Jul;23(7):1615-22
8391987
Science. 1999 Jul 30;285(5428):727-9
10426993
J Exp Med. 1999 Dec 20;190(12):1801-12
10601355
Curr Opin Immunol. 2010 Apr;22(2):185-92
20074925
Eur J Immunol. 1992 Feb;22(2):483-9
1371469
J Exp Med. 2001 Mar 19;193(6):689-98
11257136
Nat Immunol. 2006 Aug;7(8):843-50
16829962
Immunity. 1998 Apr;8(4):427-38
9586633
J Immunol. 1992 Mar 1;148(5):1302-7
1371523
J Exp Med. 2000 Aug 21;192(4):537-48
10952723
Curr Opin Immunol. 2006 Oct;18(5):527-33
16879956
Science. 1997 Jun 27;276(5321):2057-62
9197272
J Immunol. 2004 Sep 1;173(5):3261-70
15322188
Nature. 2000 Mar 30;404(6777):506-10
10761920
J Exp Med. 1994 Jan 1;179(1):323-8
8270877
Immunity. 2005 May;22(5):595-606
15894277
Immunity. 2005 May;22(5):583-93
15894276
J Immunol. 2000 Aug 15;165(4):1790-8
10925256
Cell. 1992 May 1;69(3):529-37
1316241
Immunity. 1997 Jul;7(1):123-34
9252125
Eur J Immunol. 2009 Jul;39(7):1937-46
19585514
Science. 2007 Jan 12;315(5809):230-3
17218525
Immunity. 1996 Sep;5(3):217-28
8808677
J Immunol. 2002 Aug 1;169(3):1236-40
12133944
J Exp Med. 2002 Apr 1;195(7):855-67
11927630
Nature. 1989 Dec 7;342(6250):696-8
2594068
J Immunol. 2004 Apr 1;172(7):4167-75
15034029
J Exp Med. 1997 May 5;185(9):1541-7
9151891
Science. 1989 Aug 18;245(4919):746-9
2528206
Cancer Invest. 2004;22(1):106-16
15069768
J Immunol. 2004 Mar 15;172(6):3573-9
15004158
Immunol Rev. 2007 Feb;215:77-88
17291280
Nature. 1995 May 11;375(6527):155-8
7753173
Nat Immunol. 2005 Nov;6(11):1079-86
16239924
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4348-52
1584768
Immunity. 2008 Jul 18;29(1):90-100
18585064
Nat Immunol. 2006 Jan;7(1):67-75
16327787
Nat Genet. 2008 May;40(5):656-62
18408721
Mol Immunol. 2008 Jun;45(11):3253-63
18455236
Science. 1991 Jun 7;252(5011):1430-2
1828619
J Exp Med. 2008 May 12;205(5):1173-86
18443226
J Exp Med. 2000 Mar 20;191(6):937-48
10727456